Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic... Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice . The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service . Introduction Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia, which is variably defined as a serum urate level greater than either 6.8 or 7.0 mg/dl ( 1 , 2 ). Tissue deposition of monosodium urate monohydrate crystals in supersaturated extracellular fluids http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis Care and Research Wiley

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

Download PDF
16 pages

Loading next page...
 
/lp/wiley/2012-american-college-of-rheumatology-guidelines-for-management-of-TZlqOxynqt

References (142)

Publisher
Wiley
Copyright
Copyright © 2012 by the American College of Rheumatology
ISSN
2151-464X
eISSN
2151-4658
DOI
10.1002/acr.21772
pmid
23024028
Publisher site
See Article on Publisher Site

Abstract

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice . The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service . Introduction Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia, which is variably defined as a serum urate level greater than either 6.8 or 7.0 mg/dl ( 1 , 2 ). Tissue deposition of monosodium urate monohydrate crystals in supersaturated extracellular fluids

Journal

Arthritis Care and Research – Wiley

Published: Oct 1, 2012

There are no references for this article.